ATOZ HEALTH LTDActive

Company number 13640404Private limited companyIncorporated 2021
⚠ Confirmation statement overdue. It was due on 6 Oct 2026.

Key figures

−£28,930-13.9%
Net assets 2024/25
-30 k-20 k-10 k010 k2021/222022/232023/242024/25

Like most small UK companies, ATOZ HEALTH LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
025 k50 k75 k2021/222022/232023/242024/25
Filed accounts2021/22–2024/25
2021/222022/232023/242024/25
Cash at bank and in hand53,08010,4802,319138
Total assets65,83935,48027,31925,138
Total liabilities56,83352,12752,92754,067
Net assets / total equity9,006-12,284-25,391-28,930
Average number of employees1000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ATOZ HEALTH LTD

Company

ATOZ HEALTH LTD is a private limited company registered with Companies House under company number 13640404. It was incorporated on 23 Sep 2021. Its status is active. The registered office is in Manchester (M20). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460), regulation of health care, education, cultural and other social services, not incl. social security (84120), hospital activities (86101), other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files small company accounts (filleted). Net assets were −£28,930, down 13.9% on the previous year. Cash at bank and in hand was £138. Total assets were £25,138 and total liabilities £54,067. The company had an average of 0 employees. Figures are available for 4 financial years (2021/22–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 6 Oct 2026.